CXCL12 was closely associated with AS progression, and elevated expression of CXCL12 was involved in various AS pathological processes, such as dyslipidemia, inflammation, neointima hyperplasia and angiogenesis [25]. Here, CXCL12 is linked to metabolic syndrome.